Faculty of Tropical Medicine, Mahidol University

Indaptus Therapeutics Appoints Industry Veteran Roger Waltzman, M.D. Chief Medical Officer

Retrieved on: 
Monday, August 7, 2023
American literature, Drug development, Faculty of Tropical Medicine, Mahidol University, Therapy, Nilotinib, Decoy, Business administration, Hospital, Novartis, Patient, Columbia Business School, Brown University, Immunotoxin, Pharmaceutical industry

NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, announces the appointment of Roger Waltzman, M.D.

Key Points: 
  • NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, announces the appointment of Roger Waltzman, M.D.
  • as its Chief Medical Officer, effective August 7, 2023.
  • Jeffrey Meckler, Indaptus’ CEO commented, “Roger’s deep experience in drug development, particularly in the field of immuno-oncology, and his time as an officer at development and clinical-stage companies makes him an ideal candidate to assume the position of chief medical officer at Indaptus.
  • Prior, he served in the c-suite as Chief Medical Officer at Rgenix, Inc. (now Inspirna, Inc) and as Chief Scientific Officer at Jaguar Health.

Mahidol University, the Top University in Thailand, Has Officially Adopted Jolly Good's Medical VR

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Chakri Naruebodindra Medical Institute, Infection, Tropical medicine, Public health, Jane and Robert Cizik School of Nursing, Environment, Juntendo University, Institute for Health Metrics and Evaluation, Seven Is a Jolly Good Time, MHLW, Feel Good Inc., Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine, Hospital, Ministry, Knowledge, Physician, Ramathibodi Hospital, Education, Faculty, Death, Evaluation, Faculty of Tropical Medicine, Mahidol University, Mahidol University, School, Chūō-ku, Ministry of Health, Labour and Welfare, ICT, VR, Public, Medicine, Pharmaceutical industry, Tutoring, Health, Nursing

TOKYO, Nov. 30, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as "Jolly Good"), in collaboration with Juntendo University (Bunkyo-ku, Tokyo, President: Hajime Arai), will commence a demonstration project for the introduction of medical education VR for the purpose of developing medical human resources through the use of VR at Royal Mahidol University (Bangkok, Thailand, President: Prof. Banchong Mahaisavariya, hereinafter referred to as "Mahidol University") and throughout Thailand. This is the first time that Japanese medical VR has been officially introduced into an overseas university.

Key Points: 
  • This is the first time that Japanese medical VR has been officially introduced into an overseas university.
  • In this project, Jolly Good will provide Mahidol University with VR teaching material production facilities and VR experience equipment to create an environment that enables the self-production of VR teaching materials for infectious disease treatment education at the university.
  • Year 1: Build a self-production environment for VR teaching materials at Mahidol University, complete the education program, and commence operation at the university.
  • In this seminar, professors from Mahidol University will give a remote VR lecture to medical students of Juntendo University in Japan by utilizing the educational VR of Infectious Disease Education produced at Mahidol University.